Riskpilot← Back to searchSign inGet full accessUROLOGIC ApS
APSActiveCVR 31938163Vedbæk Stationsvej 6, 2. thWholesale of other household goods · NACE 4649Est. 20081 employeeswww.urox.com
Revenue 2025
DKK -76K
-629% vs 2024
EBITDA margin
142.8%
-212% vs 2024
Equity ratio
54.4%
Financial strength
Net profit 2025
DKK -109K
-212% vs 2024
| Revenue | DKK -76K | -629% |
| EBITDA | DKK -108K | -212% |
| Net profit | DKK -109K | -212% |
| Total assets | DKK 292K | -17% |
| Equity | DKK 159K | -41% |
| Employees | 1 | — |
Legal name
UROLOGIC ApS
CVR number
31938163
Legal form
Anpartsselskab
NACE code
4649 · Wholesale of other household goods
Founded
15. december 2008
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med handel og produktion og hermed beslægtet virksomhed.
Address
Vedbæk Stationsvej 6, 2. th
Phone
+4546406400
Email
urox@urox.com
Website
www.urox.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -878 | -225 | -162 | -89 | -189 | 85 | 33 | 63 | 47 | 30 | -9 | -48 | 14 | -76 |
| Staff expenses | -243 | -230 | -196 | -62 | -0 | -0 | -0 | -0 | -0 | -55 | -12 | -32 | -49 | -32 |
| EBITDA | -1.121 | -455 | -358 | -27 | -189 | 85 | 33 | 63 | 47 | -24 | -21 | -80 | -35 | -108 |
| Depreciation & amort. | -22 | -0 | -0 | -7 | -454 | -8 | -8 | -1 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -1.143 | -455 | -358 | -34 | -642 | 77 | 25 | 62 | 47 | -24 | -21 | -80 | -35 | -108 |
| Net financials | -211 | -210 | -236 | -4 | -42 | -41 | -0 | 552 | -0 | -2 | -1 | -2 | -0 | -1 |
| Profit before tax | -1.355 | -665 | -594 | -38 | -684 | 36 | 25 | 614 | 47 | -26 | -21 | -81 | -35 | -109 |
| Tax | -4 | -424 | -27 | 213 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.351 | -241 | -567 | -251 | -684 | 36 | 25 | 614 | 47 | -26 | -21 | -81 | -35 | -109 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.099 | 1.967 | 1.395 | 1.024 | 433 | 487 | 505 | 489 | 497 | 476 | 449 | 369 | 352 | 292 |
| Equity | -2.698 | -2.939 | -3.506 | -106 | -790 | -754 | -729 | -115 | -68 | 406 | 385 | 303 | 268 | 159 |
| Long-term debt | 2.612 | 3.591 | 3.624 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.186 | 1.315 | 1.278 | 1.130 | 1.223 | 1.242 | 1.234 | 604 | 565 | 70 | 64 | 66 | 83 | 133 |
| Total debt | 3.798 | 4.906 | 4.902 | 1.130 | 1.223 | 1.242 | 1.234 | 604 | 565 | 70 | 64 | 66 | 83 | 133 |
EBITDA margin
-10804900.0%
This company
15.8%
Market median
-68385543% vs market
20122025
Equity ratio
54.4%
This company
38.2%
Market median
+42% vs market
20122025
Return on equity
-68.7%
This company
18.4%
Market median
-473% vs market
20122025
Net profit margin
-10922700.0%
This company
8.1%
Market median
-134848248% vs market
20122025
Asset turnover
-0.26×
This company
1.12×
Market median
-123% vs market
20122025
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JB Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
VS Founder | Founder | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
FULDBRO HOLDING ApS | Company | 50.0% | 50.0% | 2021 |
| Individual | 20.0% | 20.0% | 2015 | |
Mens et Manus ApS | Company | 15.0% | 15.0% | 2021 |
SØSKRÆNTEN 2009 ApS | Company | 20.0% | 20.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UROLOGIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Bender | Chief Executive Officer | 0 companies |
| Vagn Steen Larsen Bender | Founder | 0 companies |
| Christian Dorfelt | Board of Directors | 0 companies |
| Henrik Rabæk Poulsen | Board of Directors | 0 companies |
| Michael Anker Mark | Board of Directors | 0 companies |